Aquestive Therapeutics, Inc. Capital Expenditures
Aquestive Therapeutics, Inc. (AQST) reported Capital Expenditures of $264.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-11
- Aquestive Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $212.00K, a 98.13% increase year-over-year.
- Aquestive Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $52.00K, a 61.48% decline year-over-year.
- Aquestive Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $85.00K, a 466.67% increase year-over-year.
- Aquestive Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $235.00K, a 193.75% increase year-over-year.
- Aquestive Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $562.00K, a 253.46% increase from fiscal 2024.
- Aquestive Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $159.00K, a 84.02% decline from fiscal 2023.
- Aquestive Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $995.00K, a 2.83% decline from fiscal 2022.
- Aquestive Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $1.02M, a 12.16% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $212.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $264.00K 10-Q · filed 2026-08-11 | $349.00K derived: sum of 3 quarters · filed 2026-08-11 | $584.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $52.00K 10-Q · filed 2026-05-13 | $137.00K derived: sum of 2 quarters · filed 2026-05-13 | $372.00K derived: sum of 3 quarters · filed 2026-05-13 | $479.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $85.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $320.00K derived: sum of 2 quarters · filed 2026-03-04 | $427.00K derived: sum of 3 quarters · filed 2026-08-11 | $562.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | $235.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $342.00K derived: sum of 2 quarters · filed 2026-08-11 | $477.00K 10-Q · filed 2025-11-05 | $492.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $242.00K 10-Q · filed 2026-08-11 | $257.00K derived: sum of 3 quarters · filed 2026-08-11 | $337.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $135.00K 10-Q · filed 2026-05-13 | $150.00K derived: sum of 2 quarters · filed 2026-05-13 | $230.00K derived: sum of 3 quarters · filed 2026-05-13 | $265.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $95.00K derived: sum of 2 quarters · filed 2026-03-04 | $130.00K derived: sum of 3 quarters · filed 2026-03-04 | $159.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $115.00K derived: sum of 2 quarters · filed 2025-11-05 | $144.00K 10-Q · filed 2025-11-05 | $160.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $64.00K 10-Q · filed 2025-08-11 | $80.00K derived: sum of 3 quarters · filed 2025-08-11 | $231.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $29.00K 10-Q · filed 2025-05-12 | $45.00K derived: sum of 2 quarters · filed 2025-05-12 | $196.00K derived: sum of 3 quarters · filed 2025-05-12 | $1.02M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $167.00K derived: sum of 2 quarters · filed 2025-03-05 | $993.00K derived: sum of 3 quarters · filed 2025-03-05 | $995.00K 10-K · filed 2025-03-05 |
| 2023-09-30 | $151.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $977.00K derived: sum of 2 quarters · filed 2024-11-04 | $979.00K 10-Q · filed 2024-11-04 | $1.00M derived: sum of 4 quarters · filed 2024-11-04 |
| 2023-06-30 | $826.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $828.00K 10-Q · filed 2024-08-06 | $854.00K derived: sum of 3 quarters · filed 2024-08-06 | $1.07M derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $2.00K 10-Q · filed 2024-05-07 | $28.00K derived: sum of 2 quarters · filed 2024-05-07 | $245.00K derived: sum of 3 quarters · filed 2024-05-07 | $922.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $243.00K derived: sum of 2 quarters · filed 2024-03-05 | $920.00K derived: sum of 3 quarters · filed 2024-03-05 | $1.02M 10-K · filed 2024-03-05 |
| 2022-09-30 | $217.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | $894.00K derived: sum of 2 quarters · filed 2023-11-06 | $998.00K 10-Q · filed 2023-11-06 | $1.53M derived: sum of 4 quarters · filed 2023-11-06 |
| 2022-06-30 | $677.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $781.00K 10-Q · filed 2023-08-07 | $1.31M derived: sum of 3 quarters · filed 2023-08-07 | $1.40M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $104.00K 10-Q · filed 2023-05-02 | $637.00K derived: sum of 2 quarters · filed 2023-05-02 | $720.00K derived: sum of 3 quarters · filed 2023-05-02 | $914.00K derived: sum of 4 quarters · filed 2023-05-02 |
| 2021-12-31 | $533.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $616.00K derived: sum of 2 quarters · filed 2023-03-31 | $810.00K derived: sum of 3 quarters · filed 2023-03-31 | $913.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $277.00K derived: sum of 2 quarters · filed 2022-11-01 | $380.00K 10-Q · filed 2022-11-01 | $616.00K derived: sum of 4 quarters · filed 2022-11-01 |
| 2021-06-30 | $194.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $297.00K 10-Q · filed 2022-08-02 | $533.00K derived: sum of 3 quarters · filed 2022-08-02 | $571.00K derived: sum of 4 quarters · filed 2022-08-02 |
| 2021-03-31 | $103.00K 10-Q · filed 2022-05-04 | $339.00K derived: sum of 2 quarters · filed 2022-05-04 | $377.00K derived: sum of 3 quarters · filed 2022-05-04 | $489.00K derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $236.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $274.00K derived: sum of 2 quarters · filed 2022-03-08 | $386.00K derived: sum of 3 quarters · filed 2022-03-08 | $517.00K 10-K · filed 2022-03-08 |
| 2020-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $150.00K derived: sum of 2 quarters · filed 2021-11-02 | $281.00K 10-Q · filed 2021-11-02 | $367.00K derived: sum of 4 quarters · filed 2021-11-02 |
| 2020-06-30 | $112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $243.00K 10-Q · filed 2021-08-03 | $329.00K derived: sum of 3 quarters · filed 2021-08-03 | $420.00K derived: sum of 4 quarters · filed 2021-08-03 |
| 2020-03-31 | $131.00K 10-Q · filed 2021-05-04 | $217.00K derived: sum of 2 quarters · filed 2021-05-04 | $308.00K derived: sum of 3 quarters · filed 2021-05-04 | $418.00K derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $177.00K derived: sum of 2 quarters · filed 2021-03-09 | $287.00K derived: sum of 3 quarters · filed 2021-03-09 | $663.00K 10-K · filed 2021-03-09 |
| 2019-09-30 | $91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $201.00K derived: sum of 2 quarters · filed 2020-11-04 | $577.00K 10-Q · filed 2020-11-04 | $1.07M derived: sum of 4 quarters · filed 2020-11-04 |
| 2019-06-30 | $110.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $486.00K 10-Q · filed 2020-08-04 | $976.00K derived: sum of 3 quarters · filed 2020-08-04 | $1.42M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | $376.00K 10-Q · filed 2020-05-05 | $866.00K derived: sum of 2 quarters · filed 2020-05-05 | $1.31M derived: sum of 3 quarters · filed 2020-05-05 | $1.94M derived: sum of 4 quarters · filed 2020-05-05 |
| 2018-12-31 | $490.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $938.00K derived: sum of 2 quarters · filed 2020-03-11 | $1.56M derived: sum of 3 quarters · filed 2020-03-11 | $1.82M 10-K · filed 2020-03-11 |
| 2018-09-30 | $448.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $1.07M derived: sum of 2 quarters · filed 2019-11-05 | $1.33M 10-Q · filed 2019-11-05 | $1.42M derived: sum of 4 quarters · filed 2019-11-05 |
| 2018-06-30 | $627.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $886.00K 10-Q · filed 2019-08-06 | $974.00K derived: sum of 3 quarters · filed 2019-08-06 | $1.41M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $259.00K 10-Q · filed 2019-05-08 | $347.00K derived: sum of 2 quarters · filed 2019-05-08 | $780.00K derived: sum of 3 quarters · filed 2019-05-08 | |
| 2017-12-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $521.00K derived: sum of 2 quarters · filed 2019-03-14 | $2.07M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $433.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $1.98M 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | $1.55M 10-Q · filed 2018-09-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |